Lassmann, Christian
Ilg, Winfried
Rattay, Tim W.
Schöls, Ludger
Giese, Martin
Haeufle, Daniel F. B.
Funding for this research was provided by:
Universitätsklinikum Tübingen
Article History
Received: 24 October 2022
Accepted: 19 June 2023
First Online: 15 July 2023
Declarations
:
: The study was conducted according to the Helsinki Declaration and approved by the Institutional Review Board of the University of Tübingen (reference number: 266/2017BO2) for the preSPG4 Study. In addition, written informed consent was obtained from all study participants.
: All authors approved the final version of the manuscript and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.
: C.L., T.W.R, M.G., and D.F.B.H. report no competing interest. W.I. has received consultancy honoraria by Ionis Pharmaceuticals, unrelated to the submitted work. L.S. has received consultancy fees from Vico Therapeutics, unrelated to the submitted work.